@article{JTD21053,
author = {Myron Klevansky and Thomas John},
title = {Can molecularly targeted therapy cure patients with resected EGFR mutant NSCLC?},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {Suppl 17},
year = {2018},
keywords = {},
abstract = {In an age of targeted therapies, the promise of eliminating non-targeted and indeed more toxic chemotherapy was considered a given until several trials challenged this assumption.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/21053}
}